LBVD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LBVD, covering 2025-07-03 to 2025-07-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series [Phase 2, Phase 3]